IBDEI0VU ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14654,1,3,0)
 ;;=3^Glare Sensitivity
 ;;^UTILITY(U,$J,358.3,14654,1,4,0)
 ;;=4^H53.71
 ;;^UTILITY(U,$J,358.3,14654,2)
 ;;=^5006354
 ;;^UTILITY(U,$J,358.3,14655,0)
 ;;=H53.72^^82^781^9
 ;;^UTILITY(U,$J,358.3,14655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14655,1,3,0)
 ;;=3^Impaired Contrast Sensitivity
 ;;^UTILITY(U,$J,358.3,14655,1,4,0)
 ;;=4^H53.72
 ;;^UTILITY(U,$J,358.3,14655,2)
 ;;=^5006355
 ;;^UTILITY(U,$J,358.3,14656,0)
 ;;=H57.13^^82^781^14
 ;;^UTILITY(U,$J,358.3,14656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14656,1,3,0)
 ;;=3^Ocular Pain,Bilateral
 ;;^UTILITY(U,$J,358.3,14656,1,4,0)
 ;;=4^H57.13
 ;;^UTILITY(U,$J,358.3,14656,2)
 ;;=^5006384
 ;;^UTILITY(U,$J,358.3,14657,0)
 ;;=H57.11^^82^781^16
 ;;^UTILITY(U,$J,358.3,14657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14657,1,3,0)
 ;;=3^Ocular Pain,Right Eye
 ;;^UTILITY(U,$J,358.3,14657,1,4,0)
 ;;=4^H57.11
 ;;^UTILITY(U,$J,358.3,14657,2)
 ;;=^5006382
 ;;^UTILITY(U,$J,358.3,14658,0)
 ;;=H57.12^^82^781^15
 ;;^UTILITY(U,$J,358.3,14658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14658,1,3,0)
 ;;=3^Ocular Pain,Left Eye
 ;;^UTILITY(U,$J,358.3,14658,1,4,0)
 ;;=4^H57.12
 ;;^UTILITY(U,$J,358.3,14658,2)
 ;;=^5006383
 ;;^UTILITY(U,$J,358.3,14659,0)
 ;;=I10.^^82^781^8
 ;;^UTILITY(U,$J,358.3,14659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14659,1,3,0)
 ;;=3^Hypertension,Essential
 ;;^UTILITY(U,$J,358.3,14659,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,14659,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,14660,0)
 ;;=L71.9^^82^781^19
 ;;^UTILITY(U,$J,358.3,14660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14660,1,3,0)
 ;;=3^Rosacea,Unspec
 ;;^UTILITY(U,$J,358.3,14660,1,4,0)
 ;;=4^L71.9
 ;;^UTILITY(U,$J,358.3,14660,2)
 ;;=^5009276
 ;;^UTILITY(U,$J,358.3,14661,0)
 ;;=L71.8^^82^781^18
 ;;^UTILITY(U,$J,358.3,14661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14661,1,3,0)
 ;;=3^Rosacea NEC
 ;;^UTILITY(U,$J,358.3,14661,1,4,0)
 ;;=4^L71.8
 ;;^UTILITY(U,$J,358.3,14661,2)
 ;;=^5009275
 ;;^UTILITY(U,$J,358.3,14662,0)
 ;;=L71.1^^82^781^17
 ;;^UTILITY(U,$J,358.3,14662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14662,1,3,0)
 ;;=3^Rhinophyma
 ;;^UTILITY(U,$J,358.3,14662,1,4,0)
 ;;=4^L71.1
 ;;^UTILITY(U,$J,358.3,14662,2)
 ;;=^106083
 ;;^UTILITY(U,$J,358.3,14663,0)
 ;;=S05.31XA^^82^781^13
 ;;^UTILITY(U,$J,358.3,14663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14663,1,3,0)
 ;;=3^Ocular Laceration Right Eye w/o Prolapse/Loss of Intraoc Tissue,Init Encntr
 ;;^UTILITY(U,$J,358.3,14663,1,4,0)
 ;;=4^S05.31XA
 ;;^UTILITY(U,$J,358.3,14663,2)
 ;;=^5020606
 ;;^UTILITY(U,$J,358.3,14664,0)
 ;;=S05.32XA^^82^781^12
 ;;^UTILITY(U,$J,358.3,14664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14664,1,3,0)
 ;;=3^Ocular Laceration Left Eye w/o Prolapse/Loss of Intraoc Tissue,Init Encntr
 ;;^UTILITY(U,$J,358.3,14664,1,4,0)
 ;;=4^S05.32XA
 ;;^UTILITY(U,$J,358.3,14664,2)
 ;;=^5020609
 ;;^UTILITY(U,$J,358.3,14665,0)
 ;;=Z21.^^82^781^2
 ;;^UTILITY(U,$J,358.3,14665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14665,1,3,0)
 ;;=3^Asymptomatic HIV Infection Status
 ;;^UTILITY(U,$J,358.3,14665,1,4,0)
 ;;=4^Z21.
 ;;^UTILITY(U,$J,358.3,14665,2)
 ;;=^5062777
 ;;^UTILITY(U,$J,358.3,14666,0)
 ;;=Z83.511^^82^781^6
 ;;^UTILITY(U,$J,358.3,14666,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14666,1,3,0)
 ;;=3^Family Hx of Glaucoma
 ;;^UTILITY(U,$J,358.3,14666,1,4,0)
 ;;=4^Z83.511
 ;;^UTILITY(U,$J,358.3,14666,2)
 ;;=^5063382
 ;;^UTILITY(U,$J,358.3,14667,0)
 ;;=Z83.518^^82^781^5
 ;;^UTILITY(U,$J,358.3,14667,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14667,1,3,0)
 ;;=3^Family Hx of Eye Disorder NEC
